Gilead Sciences (GILD) Operating Income (2009 - 2026)
Gilead Sciences' Operating Income was $3.46 billion in Q3 2026, up 4.1% from $3.33 billion a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Operating Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gilead Sciences' Operating Income was -$2.36 billion through Sep 30, 2026; for FY2025, it came in at $10.02 billion, up 503.0% from FY2024.
- Operating Income shows a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
- In earlier years, Operating Income was $1.66 billion in FY2024 (-78.1%), $7.61 billion in FY2023 (+3.8%), $7.33 billion in FY2022 (-26.1%) and $9.92 billion in FY2021 (+143.6%).
- The Q3 2026 figure marks the highest quarterly Operating Income since Q3 2021.
- Compared with a year earlier, Operating Income was higher in four of the last six quarters, with growth averaging 53.5%.
- The best year-over-year quarter for Operating Income over five years was Q1 2023 (growth of 765.5%); the worst was Q1 2022 (a decline of 93.2%).
- Per Business Quant data, GILD's Operating Income in the three quarters before Q3 2026 was -$10.39 billion (Q2 2026), $2.59 billion (Q1 2026) and $1.98 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 712.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.46 Bn |
| Jun 30, 2026 | -10.39 Bn |
| Mar 31, 2026 | 2.59 Bn |
| Dec 31, 2025 | 1.98 Bn |
| Sep 30, 2025 | 3.33 Bn |
| Jun 30, 2025 | 2.47 Bn |
| Mar 31, 2025 | 2.24 Bn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 888.00 Mn |
| Jun 30, 2024 | 2.64 Bn |
| Mar 31, 2024 | -4.32 Bn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 1.67 Bn |
| Mar 31, 2023 | 1.71 Bn |
| Dec 31, 2022 | 2.27 Bn |
| Sep 30, 2022 | 2.84 Bn |
| Jun 30, 2022 | 2.03 Bn |
| Mar 31, 2022 | 197.00 Mn |
| Dec 31, 2021 | 940.00 Mn |
API Access
Gilead Sciences Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();